MARKET VECTORS ETF TR - BIOTECH ETF (BBH)

CUSIP: 57060U183

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class
Equity / BIOTECH ETF
Total 13F shares
1,073,463
Share change
-125,319
Total reported value
$111,469,248
Put/Call ratio
61%
Price per share
$103.68
Number of holders
63
Value change
-$16,592,864
Number of buys
23
Number of sells
53

Quarterly Holders Quick Answers

What is CUSIP 57060U183?
CUSIP 57060U183 identifies BBH - MARKET VECTORS ETF TR - BIOTECH ETF in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MARKET VECTORS ETF TR - BIOTECH ETF (BBH) as of Q1 2016

As of 31 Mar 2016, MARKET VECTORS ETF TR - BIOTECH ETF (BBH) was held by 63 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,073,463 shares. The largest 10 holders included MORGAN STANLEY, GOLDMAN SACHS GROUP INC, UBS Group AG, LPL Financial LLC, CITIGROUP INC, BB&T CORP, MURPHY CAPITAL MANAGEMENT INC, ROYAL BANK OF CANADA, BANQUE PICTET & CIE SA, and CITADEL ADVISORS LLC. This page lists 63 institutional shareholders reporting positions in this security for the Q1 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.